AnaCardio pumps €19 million into heart failure treatment innovation | EU-Startups
AnaCardio, a clinical-stage biopharmaceutical startup headquartered in Stockholm, has secured €17.8 million in a Series A extension round to develop their
10 Jan 11:33 · EU-Startups